Novel vaccines for glioblastoma: clinical update and perspective.

about

Cancer vaccine clinical trials.Glioblastoma under Siege: An Overview of Current Therapeutic Strategies.Survivin-Based Treatment Strategies for Squamous Cell Carcinoma.Novel Immunotherapeutics for the Treatment of Glioblastoma: The Last Decade of Research.

P2860

Q38780732-5EEE080B-BDB3-480E-9574-5B1F572FDF45 Q47553080-38AA7E5B-AF0E-4160-AB0A-2E79C69DECF1 Q51758973-62FA91FB-865E-4048-B827-388BA2C62F73 Q52564518-E4018F93-E2C0-4C5E-9D8A-55E734FC840B

P2860

Novel vaccines for glioblastoma: clinical update and perspective.

Item

http://www.wikidata.org/entity/Q39043417

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Novel vaccines for glioblastoma: clinical update and perspective.

@en

Novel vaccines for glioblastoma: clinical update and perspective.

@nl

type

Item

label

Novel vaccines for glioblastoma: clinical update and perspective.

@en

Novel vaccines for glioblastoma: clinical update and perspective.

@nl

prefLabel

Novel vaccines for glioblastoma: clinical update and perspective.

@en

Novel vaccines for glioblastoma: clinical update and perspective.

@nl

P1476

Novel vaccines for glioblastoma: clinical update and perspective.

@en

P2093

Evan K Winograd

http://www.w3.org/2001/XMLSchema#string

Michael J Ciesielski

http://www.w3.org/2001/XMLSchema#string

Robert A Fenstermaker

http://www.w3.org/2001/XMLSchema#string

P2860

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Structural and functional features of central nervous system lymphatic vessels.

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

How TCRs bind MHCs, peptides, and coreceptors

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

P304

1293-1308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT-2016-0059

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27993092

http://www.w3.org/2001/XMLSchema#string

P932

5619015

http://www.w3.org/2001/XMLSchema#string

Novel vaccines for glioblastoma: clinical update and perspective.

about

P2860

P2860

Novel vaccines for glioblastoma: clinical update and perspective.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932